0001209191-18-047796.txt : 20180821 0001209191-18-047796.hdr.sgml : 20180821 20180821173717 ACCESSION NUMBER: 0001209191-18-047796 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170613 FILED AS OF DATE: 20180821 DATE AS OF CHANGE: 20180821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAU JOHNSON YIU NAM CENTRAL INDEX KEY: 0001181165 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 181031023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2017-06-13 2017-06-21 0 0001300699 Athenex, Inc. ATNX 0001181165 LAU JOHNSON YIU NAM C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 1 1 0 CEO and Chairman of the Board Stock Option (Right to Buy) 11.00 2017-06-13 4 A 0 1 0.00 A 2018-06-13 2027-06-13 Common Stock 1 1 D This option was previously reported by Dr. Lau. This amendment is being filed to correct the transaction date, exercise date, and expiration date. /s/ Teresa Bair, Attorney-in-Fact 2018-08-21